Aarti Drugs reclaimed 50-DMA in style; the stock jumped 2.9% on the back of solid results. Revenue was up at 35% y/y to Rs 374.3 crore, beating consensus estimates of Rs 341.1 crore. Net profit grew 105% to Rs 23.4 crore. The stock is 1% below its 200-DMA.
